Figures & data
Table 1. Patient and tumor characteristics of the total study population of patients with metachronous metastases from primary resected stage I–III CRC treated with palliative systemic therapy (n = 385).
Figure 1. First-line chemotherapeutic regimens according to age at time of diagnosis of metachronous metastases (n = 385).
Table 2. Palliative systemic treatment of metachronous metastases from primary resected CRC, according to age at diagnosis of metastatic disease (n = 385).
Figure 2. Proportion of patients receiving second and further lines of systemic treatment (a), according to age at time of diagnosis of metachronous metastases (b) (n = 385).
Table 3. Predictors of treatment with second-line treatment and exposure to all three available cytotoxic agents, adjusted for all factors listed (n = 385).